Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Abroad (travel likely)RecruitingPHASE1
Conditions
Acute Myeloid Leukemia · Chronic Myeloid Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndromes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Kansas Cancer Center, Westwood, Kansas, United States
Ohio State University Medical Center, Columbus, Ohio, United States
Study leads
Joseph McGuirk, M.D.
Principal Investigator
University of Kansas Medical Center